Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report
Asumda, Faizal Z., Kraker, Jessica A. , Thomas, Sarah , Maleszewski, Joseph J. , Stone, Edwin M. , Lanpher, Brendan C. , Schimmenti, Lisa A. , Thomas, Sarah C, Maleszewski, Joseph, Schimmenti, Lisa A , Thomas, Sarah C.

Mayo Clinic

Therapeutic Advances in Rare Disease | January 13, 2023 | Volume: 4 | Issue: No issue available | Pages: No page available

10.1177/26330040221145945 | PMID 37181073 Get It

Mucopolysaccharidoses (MPS) are a group of inherited lysosomal storage disorders caused by deficient levels and/or activity of glycosaminoglycan (GAG)-degradative enzymes. MPS are characterized by accumulation of the mucopolysaccharides heparan sulfate, dermatan sulfate, keratan sulfate, or chondroitin sulfate in tissues. We report the case of a 38-year-old woman with a history of joint restriction and retinitis pigmentosa who developed bivalvular heart failure requiring surgery. It was not until pathological examination of surgically excised valvular tissue that a diagnosis of MPS I was made. Her musculoskeletal and ophthalmologic symptoms, when placed in the context of MPS I, painted the diagnostic picture of a genetic syndrome that was overlooked until a diagnosis was made in late middle age.
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists
Donskov, Agnete Overgaard , Mackie, Sarah , Hauge, Ellen‐Margrethe , Gutiérrez, Carlos Enrique Toro , Hansen, Ib Tønder , Hemmig, Andrea Katharina , Maas, Aatke van der , Gheita, Tamer A. , Nielsen, Berit Dalsgaard , Douglas, Karen, Matteson, Eric L. , Matza, Mark , Ocampo, Vanessa , Grainger, Rebecca , Bran, Andrea, Appenzeller, Simone , Goecke, Annelise, Colmán, Nelly , Keen, Helen , Kuwana, Masataka , Gupta, Latika, Salim, Babur , Harifi, Ghita , Erraoui, M. , Ziadé, Nelly , Al-Ani, Nizar Abdulateef, Ajibade, Adeola , Frølund, Line L. , Yates, Max , Pimentel-Quiroz, Víctor R. , Lyrio, André Marun , Sandovici, Maria , Geest, Kornelis S. M. van der , Brouwer, Elisabeth , Dejaco, Christian , Keller, Kresten Krarup , Gupta, Latika , Mackie, Sarah Louise , Gheita, Tamer , Conway, Richard , Monti, Sara , Sattui, Sebastian E , Grainger, Rebecca , Keen, Helen , Kuwana, Masataka , Gupta, Latika , Ziade, Nelly , Knitza, Johannes , Pimentel-Quiroz, Victor R , Van der Geest, Kornelis S M , Dejaco, Christian , Keller, Kresten Krarup , Yates, Max , Conway, Richard , Rezuş, Elena , Dasgupta, Bhaskar , Monti, Sara , Sattui, Sebastian E. , Gromova, Margarita Aleksandrovna , Helliwell, Toby

Mayo Clinic

Rheumatology | January 12, 2023 | Volume: 62 | Issue: 8 | Pages: 2797-2805

10.1093/rheumatology/keac713 | PMID 36637182 Get It

Abstract Objectives To explore current management practices for PMR by general practitioners (GPs) and rheumatologists including implications for clinical trial recruitment. Methods An English language questionnaire was constructed by a working group of rheumatologists and GPs from six countries. The questionnaire focused on: 1: Respondent characteristics; 2: Referral practices; 3: Treatment with glucocorticoids; 4: Diagnostics; 5: Comorbidities; and 6: Barriers to research. The questionnaire was distributed to rheumatologists and GPs worldwide via members of the International PMR/Giant Cell Arteritis Study Group. Results In total, 394 GPs and 937 rheumatologists responded to the survey. GPs referred a median of 25% of their suspected PMR patients for diagnosis and 50% of these were returned to their GP for management. In general, 39% of rheumatologists evaluated patients with suspected PMR >2 weeks after referral, and a median of 50% of patients had started prednisolone before rheumatologist evaluation. Direct comparison of initial treatment showed that the percentage prescribing >25 mg prednisolone daily for patients was 30% for GPs and 12% for rheumatologists. Diagnostic imaging was rarely used. More than half (56%) of rheumatologists experienced difficulties recruiting people with PMR to clinical trials. Conclusion This large international survey indicates that a large proportion of people with PMR are not referred for diagnosis, and that the proportion of treatment-naive patients declined with increasing time from referral to assessment. Strategies are needed to change referral and management of people with PMR, to improve clinical practice and facilitate recruitment to clinical trials.
Use of Obstetric and Gynecologic Hospitalists Is Associated With Decreased Severe Maternal Morbidity in the United States
Torbenson, Vanessa E. , Tatsis, Vasiliki, Butler, Jennifer , Kjerulff, Lucy, McLaughlin, G. Blake, Stika, Catherine S. , Tappin, Dyanne, VanBlaricom, Amy, Mehta, Ramila A. , McCue, Brigid , Mehta, Ramila, Bradley, Sarah L., McLaughlin, G. Blake, Branda, Megan E.

Mayo Clinic

Journal of Patient Safety | January 11, 2023 | Volume: 19 | Issue: 3 | Pages: 202-210

10.1097/pts.0000000000001102 | PMID 36630491 Get It

Objectives This study aimed to evaluate the prevalence of obstetric and gynecologic (Ob/Gyn) hospitalists and determine if an association exists between the presence of Ob/Gyn hospitalists and severe maternal morbidity (SMM). Methods This observational study included data from hospitals listed in the USA TODAY’s 2019 article titled, “Deadly deliveries: Childbirth complication rates at maternity hospitals.” Telephone and email surveys of staff in these hospitals identified the presence or absence of continuous providers in the hospital 24 hours, 7 days a week (24/7 coverage) and the types of providers who are employed, then compared these responses with the SMM cited by USA TODAY. Results Eight hundred ten hospitals were contacted, with participation from 614 labor and delivery units for a response rate of 75.8%. Fifty-seven percent of units were staffed with 24/7 coverage, with 46% of hospitals’ coverage primarily provided by an Ob/Gyn hospitalist and 54% primarily by a nonhospitalist OB/Gyn provider. The SMM and presence of 24/7 coverage increased with the level of neonatal care and delivery volume. Of hospitals with 24/7 coverage, those that primarily used Ob/Gyn hospitalists had a lower SMM for all mothers (1.7 versus 2.0, P = 0.014) and for low-income mothers (1.9 versus 2.30, P = 0.007) than those who primarily used nonhospitalist OB/Gyn providers. Conclusions Severe maternal morbidity increases with delivery volume, level of neonatal care, and 24/7 coverage. Of hospitals with 24/7 coverage, units that staff with Ob/Gyn hospitalists have lower levels of SMM than those that use nonhospitalist Ob/Gyn providers.
Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer’s disease
Wheelock, Muriah D. , Strain, Jeremy F. , Mansfield, Patricia K. , Tu, Jiaxin Cindy , Tanenbaum, Aaron , Preische, Oliver, Chhatwal, Jasmeer P. , Cash, David M. , Fagan, Anne M. , Fox, Nick C. , Graff‐Radford, Neill R. , Hassenstab, Jason , Jack, Clifford R. , Xiong, Chengjie , Perrin, Richard J. , Xiong, Chengjie , Morris, John C. , Ances, Beau M. , Eggebrecht, Adam T. , Gordon, Brian A. , Network, the Dominantly Inherited Alzheimer, Adams, Sarah , Araki, Aki, Barthélemy, Nicolas R. , Bechara, Jacob , Berman, Sarah , Bodge, Courtney, Brandon, Susan E. , Brooks, W. K. , Brosch, Jared R. , Buck, Jill , Buckles, Virginia, Cash, Lisa, Chen, Charlie, Chrem, Patricio, Chua, Jasmin, Chui, Helena, Cruchaga, Carlos , Day, Gregory S. , Cruz, Chrismary De La, Denner, Darcy, Diffenbacher, Anna, Dincer, Aylin , Donahue, Tamara, Egido, Noelia , Esposito, Bianca, Farlow, Marty, Feldman, Becca , Fitzpatrick, Colleen , Franklin, Erin , Friedrichsen, Nelly, Gardener, Samantha L. , Goate, Alison , Goldberg, Sarah B. , Gonzalez, Alyssa, Gräber‐Sultan, Susanne, Graham, Morgan, Gray, Julia, Gremminger, Emily, Groves, Alex, Haass, Christian , Häsler, Lisa M., Hellm, Cortaiga, Herries, Elizabeth, Hoechst-Swisher, Laura, Hornbeck, Russ C. , Igor, Yakushev, Ihara, Ryoko , Ikonomović, Snežana, Ishii, Kenji , Jerome, Gina, Käser, Stephan, Keefe, Sarah , Klunk, William E. , Koudelis, Deb, Kuder-Buletta, Elke, Laske, Christoph , Martinez, Rita, Mason, Neal Scott, Mawuenyega, Kwasi G., Mejia, Arlene, Morenas‐Rodríguez, Estrella , Mori, Hiroshi , Mountz, James M. , Mummery, Cath, Nadkami, Neelesh, Nagamatsu, Akemi, Neimeyer, Katie, Norton, Joanne, Nuscher, Brigitte , Obermüller, Ulricke, Patira, Riddhi , Ping, Lingyan, Ringman, John M. , Salloway, Stephen , Senda, Michio , Seyfried, Nick , Shady, Kristine, Sigurdson, Wendy, Smith, Lori, Snitz, Beth E. , Sohrabi, Hamid R. , Stephens, Sochenda, Taddei, Kevin , Thompson, Sarah , Vöglein, Jonathan , Wang, Peter, Weamer, Elise A., Xu, Jinbin , Cruchaga, Carlos , Fagan, Anne M , Fox, Nick C , Graff-Radford, Neill R , Hassenstab, Jason , Jack, Clifford R , Karch, Celeste M , Xiong, Chengjie , McDade, Eric M , Schofield, Peter R , Xiong, Chengjie , Morris, John C , Bateman, Randall J , Jucker, Mathias , Benzinger, Tammie L S , Ances, Beau M , Eggebrecht, Adam T , Gordon, Brian A , Cruchaga, Carlos , Day, Gregory S , Vöglein, Jonathan , Cash, David M , Goate, Alison M , Berman, Sarah , Karch, Celeste M. , McDade, Eric , Schofield, Peter R. , Bateman, Randall J. , Benzinger, Tammie L.S. , Network, the Dominantly Inherited Alzheimer, Allegri, Ricardo , Brandon, Susan, Brooks, William (Bill), Buck, Jill, Carter, Kathleen, Douglas, Jane, Duong, Duc M , Feldman, Becca, Fitzpatrick, Colleen, Flores, Shaney , Fujii, Hisako , Ghetti, Bernardino , Goldman, Jill , Grilo, Miguel, Hofmann, Anna, Holtzman, David M. , Ikeuchi, Takeshi , Johnson, Erik C. B. , Kasuga, Kensaku , Koeppe, Robert A. , Lee, Jae‐Hong , Levey, Allan I. , Li, Yan , López, Oscar L. , Marsh, Jacob, Martins, Ralph N. , Masters, Colin L. , McCullough, Austin , Niimi, Yoshiki , Noble, James M. , O’Connor, Antoinette , Ping, Lingyan, Renton, Alan , Sánchez‐Valle, Raquel , Shimada, Hiroyuki , Smith, Jennifer A. , Thompson, Sarah, Wang, Qing , Xu, Xiong

Mayo Clinic

Brain | January 10, 2023 | Volume: 146 | Issue: 7 | Pages: 2928-2943

10.1093/brain/awac498 | PMID 36625756 Get It

Abstract Neurofilament light chain, a putative measure of neuronal damage, is measurable in blood and CSF and is predictive of cognitive function in individuals with Alzheimer’s disease. There has been limited prior work linking neurofilament light and functional connectivity, and no prior work has investigated neurofilament light associations with functional connectivity in autosomal dominant Alzheimer’s disease. Here, we assessed relationships between blood neurofilament light, cognition, and functional connectivity in a cross-sectional sample of 106 autosomal dominant Alzheimer’s disease mutation carriers and 76 non-carriers. We employed an innovative network-level enrichment analysis approach to assess connectome-wide associations with neurofilament light. Neurofilament light was positively correlated with deterioration of functional connectivity within the default mode network and negatively correlated with connectivity between default mode network and executive control networks, including the cingulo-opercular, salience, and dorsal attention networks. Further, reduced connectivity within the default mode network and between the default mode network and executive control networks was associated with reduced cognitive function. Hierarchical regression analysis revealed that neurofilament levels and functional connectivity within the default mode network and between the default mode network and the dorsal attention network explained significant variance in cognitive composite scores when controlling for age, sex, and education. A mediation analysis demonstrated that functional connectivity within the default mode network and between the default mode network and dorsal attention network partially mediated the relationship between blood neurofilament light levels and cognitive function. Our novel results indicate that blood estimates of neurofilament levels correspond to direct measurements of brain dysfunction, shedding new light on the underlying biological processes of Alzheimer’s disease. Further, we demonstrate how variation within key brain systems can partially mediate the negative effects of heightened total serum neurofilament levels, suggesting potential regions for targeted interventions. Finally, our results lend further evidence that low-cost and minimally invasive blood measurements of neurofilament may be a useful marker of brain functional connectivity and cognitive decline in Alzheimer’s disease.
Genomic markers of recurrence risk in atypical meningioma following gross total resection
Vaubel, Rachael A. , Weiskittel, Taylor M. , Jenkins, Sarah M. , Dasari, Surendra , Uhm, Joon H. , Brown, Paul D. , Gompel, Jamie J. Van , Jenkins, Robert B. , Kipp, Benjamin R. , Sukov, William R. , Weiskittel, Taylor M , Van Gompel, Jamie J , Kipp, Benjamin , Sukov, William , Giannini, Caterina , Raghunathan, Aditya , Vaubel, Rachael A , Kumar, Rahul , Lachance, Daniel Honore , Giannini, Caterina , Johnson, Derek R. , Raghunathan, Aditya

Mayo Clinic

Neuro-Oncology Advances | January 10, 2023 | Volume: 5 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdad004 | PMID 36845294 Get It

AbstractBackgroundMeningiomas are the most common primary central nervous system (CNS) tumor in adults and CNS World Health Organization grade 2 (atypical) meningiomas show an intermediate risk of recurrence/progression. Molecular parameters are needed to better inform management following gross total resection (GTR).MethodsWe performed comprehensive genomic analysis of tumor tissue from 63 patients who underwent radiologically confirmed GTR of a primary grade 2 meningioma, including a CLIA-certified target next-generation sequencing panel (n = 61), chromosomal microarray (n = 63), genome-wide methylation profiling (n = 62), H3K27me3 immunohistochemistry (n = 62), and RNA-sequencing (n = 19). Genomic features were correlated with long-term clinical outcomes (median follow-up: 10 years) using Cox proportional hazards regression modeling and published molecular prognostic signatures were evaluated.ResultsThe presence of specific copy number variants (CNVs), including -1p, -10q, -7p, and -4p, was the strongest predictor of decreased recurrence-free survival (RFS) within our cohort (P < .05). NF2 mutations were frequent (51%) but did not show a significant association with RFS. DNA methylation-based classification assigned tumors to DKFZ Heidelberg benign (52%) or intermediate (47%) meningioma subclasses and was not associated with RFS. H3K27 trimethylation (H3K27me3) was unequivocally lost in 4 tumors, insufficient for RFS analysis. Application of published integrated histologic/molecular grading systems did not improve prediction of recurrence risk over the presence of -1p or -10q alone.ConclusionsCNVs are strong predictors of RFS in grade 2 meningiomas following GTR. Our study supports incorporation of CNV profiling into clinical evaluation to better guide postoperative patient management, which can be readily implemented using existing, clinically validated technologies.
The Effects of Combined Exposure to Simulated Microgravity, Ionizing Radiation, and Cortisol on the In Vitro Wound Healing Process
Radstake, Wilhelmina E. , Gautam, Kiran , Miranda, Silvana , Vermeesen, Randy , Tabury, Kevin , Rehnberg, Emil , Buset, Jasmine, Janssen, Ann, Leysen, Liselotte, Neefs, Mieke, Claesen, Jürgen , Goethem, Marc‐Jan van, Parisi, Alessio , Durante, Marco , Baselet, Bjorn , Baatout, Sarah , Parisi, Alessio , Durante, Marco , Baselet, Bjorn , Baatout, Sarah , Verslegers, Mieke , Weber, Uli Andreas , Fournier, Claudia , Brandenburg, Sytze

Mayo Clinic

Cells | January 9, 2023 | Volume: 12 | Issue: 2 | Pages: 246

10.3390/cells12020246 | PMID 36672184 Get It

Human spaceflight is associated with several health-related issues as a result of long-term exposure to microgravity, ionizing radiation, and higher levels of psychological stress. Frequent reported skin problems in space include rashes, itches, and a delayed wound healing. Access to space is restricted by financial and logistical issues; as a consequence, experimental sample sizes are often small, which limits the generalization of the results. Earth-based simulation models can be used to investigate cellular responses as a result of exposure to certain spaceflight stressors. Here, we describe the development of an in vitro model of the simulated spaceflight environment, which we used to investigate the combined effect of simulated microgravity using the random positioning machine (RPM), ionizing radiation, and stress hormones on the wound-healing capacity of human dermal fibroblasts. Fibroblasts were exposed to cortisol, after which they were irradiated with different radiation qualities (including X-rays, protons, carbon ions, and iron ions) followed by exposure to simulated microgravity using a random positioning machine (RPM). Data related to the inflammatory, proliferation, and remodeling phase of wound healing has been collected. Results show that spaceflight stressors can interfere with the wound healing process at any phase. Moreover, several interactions between the different spaceflight stressors were found. This highlights the complexity that needs to be taken into account when studying the effect of spaceflight stressors on certain biological processes and for the aim of countermeasures development.
Abstract P056: Germline cancer susceptibility gene testing in unselected patients with soft tissue sarcoma: a multi-center prospective study
Ailts, Isaak , Golafshar, Michael A. , Klint, Margaret, Barrus, Kathleen , Nussbaum, Samuel R., Leach, Brandie, Young, Sarah , Samadder, N. Jewel , Seetharam, ­Mahesh , Golafshar, Michael , Kunze, Katie L. , Esplin, Edward D. , Leach, Brandie

Mayo Clinic

Cancer Prevention Research | January 4, 2023 | Volume: 16 | Issue: 1_Supplement | Pages: P056-P056

10.1158/1940-6215.precprev22-p056 Get It

Abstract Sarcomas are rare heterogenous mesenchymal tumors with over 75 different subtypes, with varying biology and outcomes, with no clear inciting factor in the vast majority. The germline genetic susceptibility to sarcoma is not very well characterized. Identification of any underlying germline predisposition can have important implications for treatment of patients and screening recommendations for family members. To determine the prevalence of pathogenic germline variants (PGV) in patients with sarcomas, we undertook the Interrogating Cancer Etiology Using Proactive Genetic Testing (INTERCEPT) study, a prospective multi-site study of germline sequencing using a >80-gene next-generation sequencing platform. The study was done at the three Mayo Clinic Cancer Centers between April 1, 2018, and March 31, 2020. Patients were not selected based on stage, family cancer history, ethnicity, or age. Family cascade testing was offered at no charge. Results: 115 adult patients with soft tissue sarcoma were included in the study. The median age was 60 years, 58.5% were male, 81% were White. The anatomical location of the primary tumor included extremities (33.0%), retroperitoneum (18.2%), trunk (12.2%), head and neck (7.8%). Family history of cancer was present in 63% of the study population. Ten patients (8.7%) had a PGV. Thirty percent of the patients with PGV had stage IV sarcoma (3/10), and 70% (7/10) had earlier stage sarcoma (stages I-III). Among patients who were found to have a variant of uncertain significance (VUS), 40% (22/55) had stage IV sarcoma and 60% (33/55) had earlier stage disease. Of the 10 patients with PGV, high to medium penetrance gene abnormalities were identified in 8 patients (80%) involving TP53 (3), BRCA1 (1), SDHA (1), ATM (2) and heterozygous deletion of NBN (1) genes. Of these PGV, gene deletions were observed in 6/10 while missense variants comprised the remaining 4. The vast majority of the PGV (70%) would not have been identified using the current guidelines utilizing the 2018 or 2020 National Comprehensive Cancer Network (NCCN), National Society of Genetic Counselors (NSGC) or American College of Medical Genetics and Genomics. Conclusion: In this prospective, multi-site study comprising over 100 patients with diverse sarcomas, unselected germline testing identified a PGV in 1 in 11 patients (8.7%) with the majority of these not being detected using current standard of care guidelines for genetic testing. Because of the rarity of sarcomas, in addition to limited effective treatment options for advanced disease, large scale germline testing in sarcomas represents a potentially impactful strategy to assess therapeutic options and for assessment of familial risk. Citation Format: Isaak Ailts, Michael A. Golafshar, Katie L. Kunze, Margaret Klint, Kathleen Barrus, Samuel Nussbaum, Edward Esplin, Brandie Leach, Sarah Young, Niloy Jewel Samadder, Mahesh Seetharam. Germline cancer susceptibility gene testing in unselected patients with soft tissue sarcoma: a multi-center prospective study. [abstract]. In: Proceedings of the AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer; 2022 Nov 17-19; Austin, TX. Philadelphia (PA): AACR; Can Prev Res 2023;16(1 Suppl): Abstract nr P056.
Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research
Gutierrez, Amanda M. , Robinson, Jill O. , Raesz-Martinez, Robin, Canfield, Isabel , Majumder, Mary A. , Scollon, Sarah , Desrosiers, Lauren , Hsu, Rebecca , Allen‐Rhoades, Wendy , Parsons, D. Williams , Malek, Janet , Hsu, Rebecca L , Parsons, D Williams , Allen-Rhoades, Wendy A , Scollon, Sarah R , Desrosiers-Battu, Lauren R , Plon, Sharon E. , McGuire, Amy L

Mayo Clinic

Journal of Adolescent and Young Adult Oncology | January 3, 2023 | Volume: 12 | Issue: 5 | Pages: 773-781

10.1089/jayao.2022.0066 | PMID 36595372 Get It

The extracellular ATP receptor P2RX7 imprints a pro-memory transcriptional signature in effector CD8+ T cells
Dijk, Sarah van , Vardam-Kaur, Trupti , Silva, Henrique Borges da

Mayo Clinic

The Journal of Immunology | January 3, 2023 | Volume: 208 | Issue: Supplement_1 | Pages: 57.05-57.05

10.4049/jimmunol.208.supp.57.05 Get It

Abstract Development of central memory (Tcm) and resident memory (Trm) CD8+ T cells, which respectively promote immunity in the circulation and in barrier tissues, is not completely understood. Tcm and Trm cells may arise from common precursors, however their fate-inducing signals are elusive. We found that virus-specific effector CD8+ T cells display heterogeneous expression of the extracellular ATP sensor P2RX7. P2RX7-high expression is confined, at peak effector phase, to CD62L+ memory precursors which preferentially form Tcm cells. Among early effector CD8+ T cells, asymmetrical P2RX7 distribution correlated with distinct transcriptional signatures, with P2RX7-high cells enriched for memory and tissue-residency sets. P2RX7-high early effectors preferentially form both Tcm and Trm cells. Defective Tcm and Trm formation in P2RX7 deficiency is significantly reverted when the transcriptional repressor Zeb2 is ablated. Mechanistically, P2RX7 negatively regulates Zeb2 expression, at least partially through TGF-β sensing in early effector CD8+ T cells. Our study indicates that unequal P2RX7 upregulation in effector CD8+ T cells is a foundational element of the early Tcm/Trm fate. Supported by grants from NIH (R00 AI139381, NIAID).